Catug

Catug Biotechnology is an innovative technology company focused on the development and application of new biopharmaceutical technologies. With research and development centers and industrialization bases in both Suzhou and Wuhan, the company aims to provide one-stop CDMO services covering the entire industrial chain for gene and cell therapy drugs and nucleic acid drugs, from product development, quality research, and clinical applications to industrialization. The company is committed to building a top-tier process technology platform, starting with several core technology service platforms: high-quality large-scale plasmid process development and production, mRNA synthesis and delivery full-process development and production, and nucleic acid analytical methods and quality research. It has successively partnered with multiple pharmaceutical companies and will continue to expand its presence in the field of new technology applications, aspiring to become a model in the next-generation innovative biotechnology industry. The core team comes from renowned institutions such as Harvard University, University of California, Ohio State University, Northeastern University, Stockholm University, Tsinghua University, Tianjin University, China Pharmaceutical University, Academy of Military Medical Sciences, as well as top international and domestic biopharmaceutical companies. They possess extensive experience in research and development, technology, and management in the fields of gene therapy and nucleic acid therapy, having successfully advanced multiple gene and cell therapy products and nucleic acid drugs from clinical stages to industrialization.